Physician profile
Juliet D Burry
NPI 1710931183
$2,382.31
in general payments reported to CMS, 2019-2025
20 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $937 · 2020: $225 · 2021: $362 · 2022: $710 · 2023: $54.07 · 2024: $93.98.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $148.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $148.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nevro Corp. | $674.43 | 2019-2024 | Senza |
| Amgen INC. | $460.87 | 2019-2022 | |
| Scilex Pharmaceuticals INC. | $276.74 | 2019-2023 | Ztlido |
| Stimwave Technologies Incorporated | $230.24 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $180.92 | 2019-2023 | Relistor |
| Novartis Pharmaceuticals Corporation | $131.21 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $129.70 | 2022 | |
| Horizon Therapeutics Plc | $32.19 | 2021 | |
| Biohaven Pharmaceutical Holding Company LTD. | $31.59 | 2022 | |
| Collegium Pharmaceutical, INC. | $30.85 | 2019-2024 | Xtampza |
| Medtronic, INC. | $30.15 | 2021 | |
| Si-Bone, INC. | $24.00 | 2019 | |
| Almatica Pharma LLC | $23.84 | 2021 | |
| Hikma Pharmaceuticals USA | $21.00 | 2022 | |
| Nalu Medical, INC. | $20.76 | 2024 | Nalu Neurostimulation System |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Grt US Holding, INC. | $19.70 | 2021 | |
| Lilly USA, LLC | $18.48 | 2022 | |
| Boston Scientific Corporation | $17.37 | 2019 | |
| Saluda Medical Americas, INC. | $14.94 | 2024 | Evoke |
| Biodelivery Sciences International, INC. | $13.33 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Juliet Burry listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.